David J. Schlanger - 07 Nov 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Executive Chairman, Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
07 Nov 2022
Net transactions value
-$321,260
Form type
4
Filing time
09 Nov 2022, 15:03:07 UTC
Previous filing
07 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $7,413 +8,146 +9.9% $0.9100* 90,694 07 Nov 2022 Direct
transaction PGNY Common Stock Sale $122,481 -3,072 -3.4% $39.87 87,622 07 Nov 2022 Direct F1, F2
transaction PGNY Common Stock Sale $204,125 -5,024 -5.7% $40.63 82,598 07 Nov 2022 Direct F1, F3
transaction PGNY Common Stock Sale $2,067 -50 -0.06% $41.34 82,548 07 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -8,146 -0.66% $0.000000 1,233,680 07 Nov 2022 Common Stock 8,146 $0.9100 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.28 to $40.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These options are fully vested and exercisable.